The U.S. Food and Drug Administration (FDA) has issued a status update for an abbreviated new drug application (ANDA) identified as ANDA083060.
The application concerns an oral tablet product named Isoniazid, 100 mg strength, manufactured by PERRIGO. The product is listed with a marketing status of “Discontinued” and is not designated as a reference drug or reference standard.
규제 업데이트2026년 8월 30일•1분 읽기
FDA Discontinues Isoniazid Tablet (ANDA083060)
FDA lists the oral Isoniazid 100 mg tablet from sponsor PERRIGO (ANDA083060) as discontinued, with no reference drug status.
PharmaCountry 팀이 정리했습니다 · 출처: FDA.gov
평점
(0)
(0)
(0)
(0)
(0)
평가 남기기